Skip to content

Fulgent Genetics, Inc. FLGT Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Revvity logo
RevvityRVTY
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Illumina logo
IlluminaILMN
CareDx logo
CareDxCDNA

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment?
Fulgent Genetics, Inc. (FLGT) reported payments to acquire property, plant, and equipment of $5.2M in Q1 2026.
How has Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment changed year-over-year?
Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment increased by 10.3% year-over-year, from $4.72M to $5.2M.
What is the long-term trend for Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s payments to acquire property, plant, and equipment has grown at a -1.3% compound annual growth rate (CAGR), from $23.81M to $22.57M.